Table 3 Comparison of F-based group vs. G-based group
Characteristics | F Group (%) | G Group (%) | P value |
|---|---|---|---|
Total Number | 144 | 99 | Â |
Median age, years (range) | 60 (range 29–80) | 61 (range 26–81) |  |
Sex | Â | Â | 0.831 |
   Male | 95 (66.0) | 64 (64.6) |  |
   Female | 49 (34.0) | 35 (35.4) |  |
ECOG performance status at baseline | Â | Â | 0.06 |
   0 – 1 | 132 (91.7) | 83 (83.8) |  |
   ≥ 2 | 12 (8.3) | 16 (16.2) |  |
Disease | Â | Â | 0.966 |
   Intrahepatic cholangiocarcinoma | 54 (37.5) | 38 (38.4) |  |
   Gallbladder cancer | 42 (29.2) | 30 (30.3) |  |
   Extrahepatic bile duct cancer | 36 (25.0) | 22 (22.2) |  |
   Ampulla of Vater carcinoma | 12 (8.3) | 9 (9.1) |  |
Relapsed disease | 51 (35.4) | 33 (33.3) | 0.737 |
Biliary stent or bypass during treatment | 31 (21.5) | 33 (33.3) | 0.04 |
Disease associated infection during treatment (cholangitis, liver abscess) | 31 (21.5) | 31 (31.3) | 0.086 |
Duration from off chemotherapy to death | 3.5 months (95% CI, 2.9–4.0) | 3.3 months (95% CI, 2.2–4.3) | 0.752 |